The recent challenges in global supply have highlighted the importance of securing vital medications like Ivermectin. Dependence on overseas manufacturers exposes nations to significant vulnerabilities, including transportation delays, cost fluctuations, and even political risks. Moving towards domestic production of Ivermectin offers a multitude o